Cost-of-Illness of Skin Cancer: A Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 751, doi. 10.1007/s40273-024-01389-5
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2024 AND VI 42 AND IP 7
Results: 8
1
2
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 811, doi. 10.1007/s40273-024-01380-0
- By:
- Publication type:
- Article
3
Bayesian Meta-Analysis of Health State Utility Values: A Tutorial with a Practical Application in Heart Failure.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 721, doi. 10.1007/s40273-024-01387-7
- By:
- Publication type:
- Article
4
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 737, doi. 10.1007/s40273-024-01377-9
- By:
- Publication type:
- Article
5
A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 797, doi. 10.1007/s40273-024-01376-w
- By:
- Publication type:
- Article
6
Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 783, doi. 10.1007/s40273-024-01374-y
- By:
- Publication type:
- Article
7
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 767, doi. 10.1007/s40273-024-01365-z
- By:
- Publication type:
- Article
8
Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 715, doi. 10.1007/s40273-024-01364-0
- By:
- Publication type:
- Article